In a
recent blog post, the FTC explained the role of closing letters issued by the staff of its Bureau of Consumer Protection.
The FTC indicates that it views the closing letters as a supplement to its enforcement activity. It states that the letters inform a company or individual that the FTC is closing its investigation into their conduct. However, the letters are not binding on the FTC.
The FTC observes that there are numerous practical reasons why its staff may close an investigation even when there is concern that a company has violated the law. For that reason, the letters make it clear that receipt of a letter should not be construed as a determination that there was no legal violation and that the FTC reserves the right to take further action.
FDA, FTC Warn Five Companies Illegally Selling Dietary Supplements Claiming to Treat Infertility
News provided by
Share this article
Share this article
SILVER SPRING, Md., May 27, 2021 /PRNewswire/ Today, the U.S. Food and Drug Administration and the Federal Trade Commission issued warning letters to five companies for illegally selling dietary supplements that claim to cure, treat, mitigate, or prevent infertility and other reproductive health disorders in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The warning letters were issued to: LeRoche Benicoeur/ConceiveEasy; EU Natural Inc.; Fertility Nutraceuticals LLC; SAL NATURE LLC/FertilHerb; and NS Products, Inc.
FDA, FTC target infertility supplements More than a year after being asked by a consumer advocacy group to take enforcement action against manufacturers of fertility supplements, FDA and FTC warned five companies in letters that their products are intended to treat diseases.
U.S. regulators on Wednesday announced sending warning letters to five companies for making unlawful claims that their dietary supplements cure, treat, mitigate or prevent infertility and other reproductive health disorders.
Such products intended to treat disease are considered drugs under the Federal Food, Drug & Cosmetic Act, even if they are labeled as dietary supplements, according to an FDA news release announcing the warning letters.
The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) announced Wednesday that they sent warning letters to five companies accusing them of illegally selling dietary supplements that allegedly treat infertility and reproductive health disorders. The agencies issued the cautionary letters to the companies last week, saying that they violated federal laws by selling their products without FDA approval and by advertising.